Global Pharmaceutical Intermediates Market Growth 2021-2026
According to this latest study, the 2021 growth of Pharmaceutical Intermediates will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Intermediates market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 167490 million in 2020. Over the next five years the Pharmaceutical Intermediates market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 215750 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Intermediates market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
GMP
Non-GMP
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Antibiotics
Antipyretic Analgesics
Vitamins
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Intermediates Consumption 2016-2026
2.1.2 Pharmaceutical Intermediates Consumption CAGR by Region
2.2 Pharmaceutical Intermediates Segment by Type
2.2.1 GMP
2.2.2 Non-GMP
2.3 Pharmaceutical Intermediates Sales by Type
2.3.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
2.3.2 Global Pharmaceutical Intermediates Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pharmaceutical Intermediates Sale Price by Type (2016-2021)
2.4 Pharmaceutical Intermediates Segment by Application
2.4.1 Antibiotics
2.4.2 Antipyretic Analgesics
2.4.3 Vitamins
2.4.4 Others
2.5 Pharmaceutical Intermediates Sales by Application
2.5.1 Global Pharmaceutical Intermediates Sale Market Share by Application (2016-2021)
2.5.2 Global Pharmaceutical Intermediates Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pharmaceutical Intermediates Sale Price by Application (2016-2021)
3 Global Pharmaceutical Intermediates by Company
3.1 Global Pharmaceutical Intermediates Sales Market Share by Company
3.1.1 Global Pharmaceutical Intermediates Sales by Company (2019-2021)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Company (2019-2021)
3.2 Global Pharmaceutical Intermediates Revenue Market Share by Company
3.2.1 Global Pharmaceutical Intermediates Revenue by Company (2019-2021)
3.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Company (2019-2021)
3.3 Global Pharmaceutical Intermediates Sale Price by Company
3.4 Global Manufacturers Pharmaceutical Intermediates Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Intermediates Product Location Distribution
3.4.2 Players Pharmaceutical Intermediates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pharmaceutical Intermediates by Region
4.1 Global Pharmaceutical Intermediates by Region
4.1.1 Global Pharmaceutical Intermediates Sales by Region
4.1.2 Global Pharmaceutical Intermediates Revenue by Region
4.2 Americas Pharmaceutical Intermediates Sales Growth
4.3 APAC Pharmaceutical Intermediates Sales Growth
4.4 Europe Pharmaceutical Intermediates Sales Growth
4.5 Middle East & Africa Pharmaceutical Intermediates Sales Growth
5 Americas
5.1 Americas Pharmaceutical Intermediates Sales by Country
5.1.1 Americas Pharmaceutical Intermediates Sales by Country (2016-2021)
5.1.2 Americas Pharmaceutical Intermediates Revenue by Country (2016-2021)
5.2 Americas Pharmaceutical Intermediates Sales by Type
5.3 Americas Pharmaceutical Intermediates Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Intermediates Sales by Region
6.1.1 APAC Pharmaceutical Intermediates Sales by Region (2016-2021)
6.1.2 APAC Pharmaceutical Intermediates Revenue by Region (2016-2021)
6.2 APAC Pharmaceutical Intermediates Sales by Type
6.3 APAC Pharmaceutical Intermediates Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Intermediates by Country
7.1.1 Europe Pharmaceutical Intermediates Sales by Country (2016-2021)
7.1.2 Europe Pharmaceutical Intermediates Revenue by Country (2016-2021)
7.2 Europe Pharmaceutical Intermediates Sales by Type
7.3 Europe Pharmaceutical Intermediates Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Intermediates by Country
8.1.1 Middle East & Africa Pharmaceutical Intermediates Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pharmaceutical Intermediates Revenue by Country (2016-2021)
8.2 Middle East & Africa Pharmaceutical Intermediates Sales by Type
8.3 Middle East & Africa Pharmaceutical Intermediates Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pharmaceutical Intermediates Distributors
10.3 Pharmaceutical Intermediates Customer
11 Global Pharmaceutical Intermediates Market Forecast
11.1 Global Pharmaceutical Intermediates Forecast by Region
11.1.1 Global Pharmaceutical Intermediates Forecast by Regions (2021-2026)
11.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pharmaceutical Intermediates Forecast by Type
11.7 Global Pharmaceutical Intermediates Forecast by Application
12 Key Players Analysis
12.1 Lonza
12.1.1 Lonza Company Information
12.1.2 Lonza Pharmaceutical Intermediates Product Offered
12.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Lonza Main Business Overview
12.1.5 Lonza Latest Developments
12.2 Catalent
12.2.1 Catalent Company Information
12.2.2 Catalent Pharmaceutical Intermediates Product Offered
12.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Catalent Main Business Overview
12.2.5 Catalent Latest Developments
12.3 Patheon
12.3.1 Patheon Company Information
12.3.2 Patheon Pharmaceutical Intermediates Product Offered
12.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Patheon Main Business Overview
12.3.5 Patheon Latest Developments
12.4 Jubilant
12.4.1 Jubilant Company Information
12.4.2 Jubilant Pharmaceutical Intermediates Product Offered
12.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Jubilant Main Business Overview
12.4.5 Jubilant Latest Developments
12.5 Granules
12.5.1 Granules Company Information
12.5.2 Granules Pharmaceutical Intermediates Product Offered
12.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Granules Main Business Overview
12.5.5 Granules Latest Developments
12.6 Ganesh
12.6.1 Ganesh Company Information
12.6.2 Ganesh Pharmaceutical Intermediates Product Offered
12.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ganesh Main Business Overview
12.6.5 Ganesh Latest Developments
12.7 Chemcon
12.7.1 Chemcon Company Information
12.7.2 Chemcon Pharmaceutical Intermediates Product Offered
12.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Chemcon Main Business Overview
12.7.5 Chemcon Latest Developments
12.8 BASF
12.8.1 BASF Company Information
12.8.2 BASF Pharmaceutical Intermediates Product Offered
12.8.3 BASF Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 BASF Main Business Overview
12.8.5 BASF Latest Developments
12.9 Porton
12.9.1 Porton Company Information
12.9.2 Porton Pharmaceutical Intermediates Product Offered
12.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Porton Main Business Overview
12.9.5 Porton Latest Developments
12.10 Lianhetech
12.10.1 Lianhetech Company Information
12.10.2 Lianhetech Pharmaceutical Intermediates Product Offered
12.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Lianhetech Main Business Overview
12.10.5 Lianhetech Latest Developments
12.11 ABA Chem
12.11.1 ABA Chem Company Information
12.11.2 ABA Chem Pharmaceutical Intermediates Product Offered
12.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 ABA Chem Main Business Overview
12.11.5 ABA Chem Latest Developments
12.12 Tianma
12.12.1 Tianma Company Information
12.12.2 Tianma Pharmaceutical Intermediates Product Offered
12.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Tianma Main Business Overview
12.12.5 Tianma Latest Developments
12.13 Jiujiujiu
12.13.1 Jiujiujiu Company Information
12.13.2 Jiujiujiu Pharmaceutical Intermediates Product Offered
12.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Jiujiujiu Main Business Overview
12.13.5 Jiujiujiu Latest Developments
12.14 Alpha
12.14.1 Alpha Company Information
12.14.2 Alpha Pharmaceutical Intermediates Product Offered
12.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Alpha Main Business Overview
12.14.5 Alpha Latest Developments
12.15 Jiuzhou
12.15.1 Jiuzhou Company Information
12.15.2 Jiuzhou Pharmaceutical Intermediates Product Offered
12.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Jiuzhou Main Business Overview
12.15.5 Jiuzhou Latest Developments
12.16 Yongtai
12.16.1 Yongtai Company Information
12.16.2 Yongtai Pharmaceutical Intermediates Product Offered
12.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Yongtai Main Business Overview
12.16.5 Yongtai Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Pharmaceutical Intermediates Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of GMP
Table 3. Major Players of Non-GMP
Table 4. Global Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 5. Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 6. Global Pharmaceutical Intermediates Revenue by Type (2016-2021) & ($ million)
Table 7. Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
Table 8. Global Pharmaceutical Intermediates Sale Price by Type (2016-2021)
Table 9. Global Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 10. Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 11. Global Pharmaceutical Intermediates Value by Application (2016-2021)
Table 12. Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021)
Table 13. Global Pharmaceutical Intermediates Sale Price by Application (2016-2021)
Table 14. Global Pharmaceutical Intermediates Sales by Company (2019-2021) & (K MT)
Table 15. Global Pharmaceutical Intermediates Sales Market Share by Company (2019-2021)
Table 16. Global Pharmaceutical Intermediates Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Pharmaceutical Intermediates Revenue Market Share by Company (2019-2021)
Table 18. Global Pharmaceutical Intermediates Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Pharmaceutical Intermediates Producing Area Distribution and Sales Area
Table 20. Players Pharmaceutical Intermediates Products Offered
Table 21. Pharmaceutical Intermediates Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Pharmaceutical Intermediates Sales by Region (2016-2021) (K MT)
Table 25. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 26. Global Pharmaceutical Intermediates Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Table 28. Americas Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 29. Americas Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 30. Americas Pharmaceutical Intermediates Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 32. Americas Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 33. Americas Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 34. Americas Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 35. Americas Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 36. APAC Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT)
Table 37. APAC Pharmaceutical Intermediates Sales Market Share by Region (2016-2021)
Table 38. APAC Pharmaceutical Intermediates Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021)
Table 40. APAC Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 41. APAC Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 42. APAC Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 43. APAC Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 44. Europe Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 45. Europe Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 46. Europe Pharmaceutical Intermediates Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 48. Europe Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 49. Europe Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 50. Europe Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 51. Europe Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT)
Table 53. Middle East & Africa Pharmaceutical Intermediates Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Pharmaceutical Intermediates Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Pharmaceutical Intermediates Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Pharmaceutical Intermediates Sales by Type (2016-2021) & (K MT)
Table 57. Middle East & Africa Pharmaceutical Intermediates Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT)
Table 59. Middle East & Africa Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Pharmaceutical Intermediates
Table 61. Key Application and Potential Industries of Pharmaceutical Intermediates
Table 62. Key Challenges of Pharmaceutical Intermediates
Table 63. Key Trends of Pharmaceutical Intermediates
Table 64. Pharmaceutical Intermediates Distributors List
Table 65. Pharmaceutical Intermediates Customer List
Table 66. Global Pharmaceutical Intermediates Sales Forecast by Region (2021-2026) & (K MT)
Table 67. Global Pharmaceutical Intermediates Consumption Market Forecast by Region
Table 68. Global Pharmaceutical Intermediates Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) & (K MT)
Table 71. Americas Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Pharmaceutical Intermediates Sales Forecast by Region (2021-2026) & (K MT)
Table 73. APAC Pharmaceutical Intermediates Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) & (K MT)
Table 75. Europe Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) & (K MT)
Table 77. Middle East & Africa Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Pharmaceutical Intermediates Sales Forecast by Type (2021-2026) & (K MT)
Table 79. Global Pharmaceutical Intermediates Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Pharmaceutical Intermediates Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Pharmaceutical Intermediates Sales Forecast by Application (2021-2026) & (K MT)
Table 83. Global Pharmaceutical Intermediates Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Pharmaceutical Intermediates Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Application (2021-2026)
Table 86. Lonza Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 87. Lonza Pharmaceutical Intermediates Product Offered
Table 88. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 89. Lonza Main Business
Table 90. Lonza Latest Developments
Table 91. Catalent Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 92. Catalent Pharmaceutical Intermediates Product Offered
Table 93. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 94. Catalent Main Business
Table 95. Catalent Latest Developments
Table 96. Patheon Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 97. Patheon Pharmaceutical Intermediates Product Offered
Table 98. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 99. Patheon Main Business
Table 100. Patheon Latest Developments
Table 101. Jubilant Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 102. Jubilant Pharmaceutical Intermediates Product Offered
Table 103. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 104. Jubilant Main Business
Table 105. Jubilant Latest Developments
Table 106. Granules Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 107. Granules Pharmaceutical Intermediates Product Offered
Table 108. Granules Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 109. Granules Main Business
Table 110. Granules Latest Developments
Table 111. Ganesh Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 112. Ganesh Pharmaceutical Intermediates Product Offered
Table 113. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 114. Ganesh Main Business
Table 115. Ganesh Latest Developments
Table 116. Chemcon Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 117. Chemcon Pharmaceutical Intermediates Product Offered
Table 118. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 119. Chemcon Main Business
Table 120. Chemcon Latest Developments
Table 121. BASF Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 122. BASF Pharmaceutical Intermediates Product Offered
Table 123. BASF Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 124. BASF Main Business
Table 125. BASF Latest Developments
Table 126. Porton Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 127. Porton Pharmaceutical Intermediates Product Offered
Table 128. Porton Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 129. Porton Main Business
Table 130. Porton Latest Developments
Table 131. Lianhetech Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 132. Lianhetech Pharmaceutical Intermediates Product Offered
Table 133. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 134. Lianhetech Main Business
Table 135. Lianhetech Latest Developments
Table 136. ABA Chem Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 137. ABA Chem Pharmaceutical Intermediates Product Offered
Table 138. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 139. ABA Chem Main Business
Table 140. ABA Chem Latest Developments
Table 141. Tianma Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 142. Tianma Pharmaceutical Intermediates Product Offered
Table 143. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 144. Tianma Main Business
Table 145. Tianma Latest Developments
Table 146. Jiujiujiu Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 147. Jiujiujiu Pharmaceutical Intermediates Product Offered
Table 148. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 149. Jiujiujiu Main Business
Table 150. Jiujiujiu Latest Developments
Table 151. Alpha Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 152. Alpha Pharmaceutical Intermediates Product Offered
Table 153. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 154. Alpha Main Business
Table 155. Alpha Latest Developments
Table 156. Jiuzhou Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 157. Jiuzhou Pharmaceutical Intermediates Product Offered
Table 158. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 159. Jiuzhou Main Business
Table 160. Jiuzhou Latest Developments
Table 161. Yongtai Basic Information, Pharmaceutical Intermediates Manufacturing Base, Sales Area and Its Competitors
Table 162. Yongtai Pharmaceutical Intermediates Product Offered
Table 163. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 164. Yongtai Main Business
Table 165. Yongtai Latest Developments
List of Figures
Figure 1. Picture of Pharmaceutical Intermediates
Figure 2. Pharmaceutical Intermediates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Intermediates Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Pharmaceutical Intermediates Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pharmaceutical Intermediates Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of GMP
Figure 10. Product Picture of Non-GMP
Figure 11. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020
Figure 12. Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021)
Figure 13. Pharmaceutical Intermediates Consumed in Antibiotics
Figure 14. Global Pharmaceutical Intermediates Market: Antibiotics (2016-2021) & (K MT)
Figure 15. Pharmaceutical Intermediates Consumed in Antipyretic Analgesics
Figure 16. Global Pharmaceutical Intermediates Market: Antipyretic Analgesics (2016-2021) & (K MT)
Figure 17. Pharmaceutical Intermediates Consumed in Vitamins
Figure 18. Global Pharmaceutical Intermediates Market: Vitamins (2016-2021) & (K MT)
Figure 19. Pharmaceutical Intermediates Consumed in Others
Figure 20. Global Pharmaceutical Intermediates Market: Others (2016-2021) & (K MT)
Figure 21. Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021)
Figure 22. Global Pharmaceutical Intermediates Revenue Market Share by Application in 2020
Figure 23. Pharmaceutical Intermediates Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Pharmaceutical Intermediates Revenue Market Share by Company in 2020
Figure 25. Global Pharmaceutical Intermediates Sales Market Share by Regions (2016-2021)
Figure 26. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2020
Figure 27. Americas Pharmaceutical Intermediates Sales 2016-2021 (K MT)
Figure 28. Americas Pharmaceutical Intermediates Revenue 2016-2021 ($ Millions)
Figure 29. APAC Pharmaceutical Intermediates Sales 2016-2021 (K MT)
Figure 30. APAC Pharmaceutical Intermediates Revenue 2016-2021 ($ Millions)
Figure 31. Europe Pharmaceutical Intermediates Sales 2016-2021 (K MT)
Figure 32. Europe Pharmaceutical Intermediates Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Pharmaceutical Intermediates Sales 2016-2021 (K MT)
Figure 34. Middle East & Africa Pharmaceutical Intermediates Revenue 2016-2021 ($ Millions)
Figure 35. Americas Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 36. Americas Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 37. Americas Pharmaceutical Intermediates Sales Market Share by Type in 2020
Figure 38. Americas Pharmaceutical Intermediates Sales Market Share by Application in 2020
Figure 39. United States Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Pharmaceutical Intermediates Sales Market Share by Region in 2020
Figure 44. APAC Pharmaceutical Intermediates Revenue Market Share by Regions in 2020
Figure 45. APAC Pharmaceutical Intermediates Sales Market Share by Type in 2020
Figure 46. APAC Pharmaceutical Intermediates Sales Market Share by Application in 2020
Figure 47. China Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 54. Europe Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 55. Europe Pharmaceutical Intermediates Sales Market Share by Type in 2020
Figure 56. Europe Pharmaceutical Intermediates Sales Market Share by Application in 2020
Figure 57. Germany Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Pharmaceutical Intermediates Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Pharmaceutical Intermediates Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Pharmaceutical Intermediates Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Pharmaceutical Intermediates Sales Market Share by Application in 2020
Figure 66. Egypt Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Pharmaceutical Intermediates Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
